Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
BRAF kinase activity
.
Show all posts
Showing posts with label
BRAF kinase activity
.
Show all posts
Wednesday, June 8, 2011
Positive results from Plexxikon's vemurafenib Phase 2 and 3 trial against metastatic melanoma
›
We know that, PLX-4032(RG7204, Vemurafenib) is a highly selective inhibitor of BRAF kinase activity, with an IC50 of 44 nmol/L against V600...
›
Home
View web version
